Literature DB >> 1618233

Development of a high performance zinc-62/copper-62 radionuclide generator for positron emission tomography.

J Zweit1, R Goodall, M Cox, J W Babich, G A Potter, H L Sharma, R J Ott.   

Abstract

Clinical utilisation of positron emission tomography could be enhanced by the availability of short-lived radionuclides derived from generator systems. The zinc-62/copper-62 combination is one such system which could be used as a source for a number of copper-62 radiopharmaceuticals. We have developed and optimised a high activity (5.6 GBq, 150 mCi) zinc-62/copper-62 generator to provide 62Cu in a form that is suitable for direct labelling of pyruvaldehyde-bis-(N4-methylthiosemicarbazone)-copper(II), Cu(PTSM). The distribution coefficients of Zn(II) and Cu(II) between anion-exchange resin and various hydrochloric acid/organic solvent mixtures were measured. Based on these measurements a generator eluent of 0.3 M HCl/40% ethanol provided 62Cu in greater than 90% yield in a 3-ml volume. A very low 62Zn breakthrough of less than 3 x 10(-7)% was achieved. Copper-PTSM was successfully labelled with the no-carrier-added 62Cu eluent directly from the generator with 94% radiochemical yield.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618233     DOI: 10.1007/bf00177368

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  19 in total

1.  62Cu-labeling of human serum albumin-dithiosemicarbazone (HSA-DTS) conjugate for regional plasma volume measurement: application of new 62Zn/62Cu generator system.

Authors:  Y Fujibayashi; K Matsumoto; Y Arano; Y Yonekura; J Konishi; A Yokoyama
Journal:  Chem Pharm Bull (Tokyo)       Date:  1990-07       Impact factor: 1.645

2.  THE ANTI-TUMOR ACTIVITY OF 2-KETO-3-ETHOXYBUTYRALDEHYDE BIS(THIOSEMICARBAZONE) AND RELATED COMPOUNDS.

Authors:  H G PETERING; H H BUSKIRK; G E UNDERWOOD
Journal:  Cancer Res       Date:  1964-04       Impact factor: 12.701

3.  Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion.

Authors:  M A Green; C J Mathias; M J Welch; A H McGuire; D Perry; F Fernandez-Rubio; J S Perlmutter; M E Raichle; S R Bergmann
Journal:  J Nucl Med       Date:  1990-12       Impact factor: 10.057

4.  Evaluation of a potential generator-produced PET tracer for cerebral perfusion imaging: single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM.

Authors:  C J Mathias; M J Welch; M E Raichle; M A Mintun; L L Lich; A H McGuire; K R Zinn; E K John; M A Green
Journal:  J Nucl Med       Date:  1990-03       Impact factor: 10.057

5.  Production of 52Fe via proton-induced reactions on manganese and nickel.

Authors:  G F Steyn; S J Mills; F M Nortier; B R Simpson; B R Meyer
Journal:  Int J Rad Appl Instrum A       Date:  1990

6.  Correlation of Cu(PTSM) localization with regional blood flow in the heart and kidney.

Authors:  A J Barnhart; W D Voorhees; M A Green
Journal:  Int J Rad Appl Instrum B       Date:  1989

7.  The zinc-62/copper-62 generator: a convenient source of copper-62 for radiopharmaceuticals.

Authors:  G D Robinson; F W Zielinski; A W Lee
Journal:  Int J Appl Radiat Isot       Date:  1980-02

8.  Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET.

Authors:  M A Green; D L Klippenstein; J R Tennison
Journal:  J Nucl Med       Date:  1988-09       Impact factor: 10.057

9.  Relation between regional myocardial uptake of rubidium-82 and perfusion: absolute reduction of cation uptake in ischemia.

Authors:  A P Selwyn; R M Allan; A L'Abbate; P Horlock; P Camici; J Clark; H A O'Brien; P M Grant
Journal:  Am J Cardiol       Date:  1982-07       Impact factor: 2.778

10.  Targeting radiopharmaceuticals: comparative biodistribution studies of gallium and indium complexes of multidentate ligands.

Authors:  C J Mathias; Y Z Sun; M J Welch; M A Green; J A Thomas; K R Wade; A E Martell
Journal:  Int J Rad Appl Instrum B       Date:  1988
View more
  8 in total

Review 1.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Authors:  Thaddeus J Wadas; Edward H Wong; Gary R Weisman; Carolyn J Anderson
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  A comparison of PET imaging characteristics of various copper radioisotopes.

Authors:  Heather Ann Williams; Simon Robinson; Peter Julyan; Jamal Zweit; David Hastings
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-29       Impact factor: 9.236

Review 3.  The development of copper radiopharmaceuticals for imaging and therapy.

Authors:  Monica Shokeen; Thaddeus J Wadas
Journal:  Med Chem       Date:  2011-09       Impact factor: 2.745

4.  Imaging zinc trafficking in vivo by positron emission tomography with zinc-62.

Authors:  George Firth; Zilin Yu; Joanna J Bartnicka; David Parker; Jana Kim; Kavitha Sunassee; Hannah E Greenwood; Fahad Al-Salamee; Maite Jauregui-Osoro; Alberto Di Pietro; Joanna Guzman; Philip J Blower
Journal:  Metallomics       Date:  2022-10-18       Impact factor: 4.636

5.  Clinical application of 62Zn/62Cu positron generator: perfusion and plasma pool images in normal subjects.

Authors:  H Okazawa; Y Fujibayashi; Y Yonekura; N Tamaki; S Nishizawa; Y Magata; K Ishizu; T Tsuchida; N Sadato; J Konishi
Journal:  Ann Nucl Med       Date:  1995-05       Impact factor: 2.668

6.  Performance of a ⁶²Zn/⁶²Cu microgenerator in kit-based synthesis and delivery of [⁶²Cu]Cu-ETS for PET perfusion imaging.

Authors:  Yen Ng; Jeffrey L Lacy; James W Fletcher; Mark A Green
Journal:  Appl Radiat Isot       Date:  2014-05-22       Impact factor: 1.513

7.  Evaluation of copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) for tissue blood flow measurement using a trapped tracer model.

Authors:  H Young; P Carnochan; J Zweit; J Babich; S Cherry; R Ott
Journal:  Eur J Nucl Med       Date:  1994-04

8.  Continuous angiotensin II infusion increases tumour: normal blood flow ratio in colo-rectal liver metastases.

Authors:  D Burke; M M Davies; J Zweit; M A Flower; R J Ott; M J Dworkin; C Glover; V R McCready; P Carnochan; T G Allen-Mersh
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.